When major diabetes device companies develop their technologies, it is often done in isolation from other diabetes device manufacturers. Many diabetes devices can only communicate, transmit information, and work with other products within their own line of products. This closed system of communication limits innovation from others developing new diabetes management tools that can collaborate with and support these products, such as transmission of device data to clinical record depositories, and advancements towards artificial pancreas systems.
To breakdown this roadblock, the team is engaged in developing interoperability standards with the Institute of Electrical and Electronics Engineering (IEEE) and the Bluetooth Special Interest Group, promoting the adoption of the standards through hosting direct, hands-on workshops with manufacturers, and continuing to improve and enhance the standards through incorporating key aspects such as cybersecurity.
Our biomedical engineers Nathaniel Hamming and Melanie Yeung made key contributions toward the development of the following ISO/IEEE 11073 and Bluetooth publications:
Dr. Joseph Cafazzo presented on diabetes industry standards at the 2014 DiabetesMine Innovation Summit at Stanford School of Medicine: